These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11014347)

  • 1. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    Arthritis Rheum; 2000 Sep; 43(9):1976-81. PubMed ID: 11014347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired production of IL-12 in systemic lupus erythematosus. III: deficient IL-12 p40 gene expression and cross-regulation of IL-12, IL-10 and IFN-gamma gene expression.
    Liu TF; Jones BM; Wong RW; Srivastava G
    Cytokine; 1999 Oct; 11(10):805-11. PubMed ID: 10525320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
    Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
    J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
    Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus.
    González-Amaro R; Portales-Pérez D; Baranda L; Abud-Mendoza C; Llorente L; Richaud-Patin Y; Alcocer-Varela J; Alarcón-Segovia D
    J Autoimmun; 1998 Oct; 11(5):395-402. PubMed ID: 9802922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
    Wong CK; Lit LC; Tam LS; Li EK; Lam CW
    Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
    Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
    Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus.
    Figueroa-Vega N; Galindo-Rodríguez G; Bajaña S; Portales-Pérez D; Abud-Mendoza C; Sánchez-Torres C; González-Amaro R
    Scand J Immunol; 2006 Dec; 64(6):668-76. PubMed ID: 17083624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
    J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus.
    Baranda L; de la Fuente H; Layseca-Espinosa E; Portales-Pérez D; Niño-Moreno P; Valencia-Pacheco G; Abud-Mendoza C; Alcocer-Varela J; González-Amaro R
    Rheumatology (Oxford); 2005 Dec; 44(12):1507-13. PubMed ID: 16251219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
    Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
    Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells.
    Wilcock LK; Francis JN; Durham SR
    Clin Exp Allergy; 2004 Sep; 34(9):1373-8. PubMed ID: 15347369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired T cell proliferation in acute dengue infection.
    Mathew A; Kurane I; Green S; Vaughn DW; Kalayanarooj S; Suntayakorn S; Ennis FA; Rothman AL
    J Immunol; 1999 May; 162(9):5609-15. PubMed ID: 10228044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.
    Llorente L; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Maillot MC; Durand-Gasselin I; Fourrier BM; Galanaud P; Emilie D
    Eur Cytokine Netw; 1993; 4(6):421-7. PubMed ID: 8186374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
    Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
    Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcitonin gene-related peptide on apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Liu C; Chen X; Jin Y; Qu R; Jiang PF; Wen GM; Tang ZH
    Clin Exp Dermatol; 2007 Nov; 32(6):650-3. PubMed ID: 17725664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant reduction of disease activity and IL-10 secreting peripheral blood mononuclear cells during immunoadsorption in patients with active systenic lupus erythematosus.
    Willeke P; Schotte H; Erren M; Schlüther B; Mickholz E; Domschke W; Gaubitz M
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):323-9. PubMed ID: 12030438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin-12 and its signaling molecules in peripheral blood mononuclear cells in systemic lupus erythematosus patients.
    Li Z; Li Y; Huang L; Xu H; Yu X; Ye R
    Chin Med J (Engl); 2002 Jun; 115(6):846-50. PubMed ID: 12123550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.